Comments on “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations” by D’Amato et al.

Abstract

We have read with interest the letter from D’Amato et al. entitled “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations”....

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

References

D'Amato G, Acanfora L, Delli Paoli L, D'Amato M. Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations. Multidisc Respir Med 2021;16:748.

Pirro M. Covid, svolta con la terapia napoletana: «Medicinali subito e nessun decesso». Available from: https://www.ilmattino.it/primopiano/sanita/coronavirus_terapia_napoletana-5726333.html

Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19 - Preliminary report. Epub 2020 Jul 17. N Engl J Med 2021;384:693-704.

Yang Z, Liu J, Zhou Y, et al. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infect 2020;81:e13-e20. DOI: https://doi.org/10.1016/j.jinf.2020.03.062

Li H, Chen C, Hu F, et al. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis. Leukemia 2020;34:1503-11. DOI: https://doi.org/10.1038/s41375-020-0848-3

Monedero P, Gea A, Castro P, Candela-Toha AM, Hernández-Sanz ML, Arruti E, et al. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study. Crit Care 2021;25:2. DOI: https://doi.org/10.1186/s13054-020-03422-3

Theoharides TC, Conti P. Dexamethasone for COVID-19? Not so fast. J Biol Regul Homeost Agents 2020;34:1241-3.

Khider L, Soudet S, Laneelle D, et al. Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19. J Med Vasc 2020;45:210-3.

Abdel-Maboud M, Menshawy A, Elgebaly A, Bahbah EI, El Ashal G, Negida A. Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis. J Thromb Thrombolysis 2020. Online Ahead of Print. DOI: https://doi.org/10.1007/s11239-020-02253-x

National Institutes of Health. COVID-19 Treatment Guidelines. Antithrombotic Therapy in Patients with COVID-19. Last Updated: December 17, 2020. Available from: https://www.covid19treatmentguidelines.nih.gov/adjunctive-therapy/antithrombotic-therapy/

Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol 2020;75:2950–73. DOI: https://doi.org/10.1016/j.jacc.2020.04.031

Italian Medicines Agency (AIFA). Low molecular weight heparins in the treatment of adult patients with COVID-19. Update: 24 November 2020. Available from: https://www.aifa.gov.it/documents/20142/1267737/Low-molecular-weight-heparins_EN_24.11.2020.pdf/fc92d837-e27a-17af-18db-9a8635fb19d5

Published
2021-04-08
Info
Issue
Section
Letters to the Editor
Keywords:
COVID-19, LMWH, steroids, home therapy
Statistics
  • Abstract views: 43

  • PDF: 10
How to Cite
Adiletta, G., Baglioni, S., Bettoncelli, G., Bracciale, P., Cazzola, M., Clini, E. M., Cutrera, R., D’Adduzio, F., De Blasio, F., Ferraro, F., Fumagalli, R., Lequaglie, C., Matera, M. G., Numis, F., Palange, P., Picciolo, S., Potena, A., Romano, F., Sabato, E., Sacchetta, A., Spatafora, M., Stefanelli, F., & Zottola, C. (2021). Comments on “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations” by D’Amato et al. Multidisciplinary Respiratory Medicine, 16. https://doi.org/10.4081/mrm.2021.757

Most read articles by the same author(s)